Cancer Pathology Data Sharing, published by HL7 International / Orders and Observations. This guide is not an authorized publication; it is the continuous build for version 1.0.1 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/HL7/cancer-reporting/ and changes regularly. See the Directory of published versions

Table of Contents

0 Table of Contents

1 Home

2 Background

3 Change Notes

4 Downloads

5 Specification

6 Artifacts Summary

6.1 Central Cancer Registry Reporting Pathology EHR Capability Statement

6.2 Pathology Laboratory Information System

6.3 IHE SDC/eCP on FHIR Observation

6.4 US Pathology Bundle

6.5 US Pathology Composition Laboratory Report

6.6 US Pathology Diagnostic Report

6.7 US Pathology Grouper Observation

6.8 US Pathology Related Practitioner Role

6.9 US Pathology Service Request

6.10 US Pathology Specimen

6.11 CAP eCC ValueSet

6.12 US Pathology Provider Types

6.13 US Pathology Section Codes

6.14 CAP eCC CodeSystem

6.15 US Pathology Code System

6.16 Additional Dimension Observation

6.17 Additional Findings Observation example

6.18 Additional Findings Section

6.19 Adrenalectomy Procedure Observation example

6.20 Breast Biomarker Testing Performed on Previous Biopsy

6.21 Breast Biomarker Testing Performed on Previous Biopsy Observation example

6.22 Breast Specimen Example

6.23 Breast Tissue Excision Observation Example

6.24 Case Summary Breast Cancer Example

6.25 Case Summary Section

6.26 Clinical History Observation example

6.27 Clinical Section

6.28 Closest Margin(s) to Invasive Carcinoma example

6.29 Comments Section

6.30 Composition - Surgical Pathology Cancer Case Summary

6.31 Distant Metastasis Observation example

6.32 Distant Metastasis Section

6.33 Ductal Carcinoma In Situ Observation Example

6.34 Estrogen Receptor (ER) Status

6.35 FIGO Stage Section

6.36 Functional Status (Notes A,B) (select all that apply) example

6.37 General Tumor Site Observation

6.38 Glandular/Tubular Differentiation Observation Example

6.39 HER2 (by immunohistochemistry)

6.40 HER2 Observation Example

6.41 Histologic Grade Observation Example

6.42 Histologic Type Observation example

6.43 Margin Distance from Invasive Carcinoma to Closest Margin example

6.44 Margin Status for Invasive Carcinoma Observation example

6.45 Margins Section

6.46 Mitotic Rate Observation Example

6.47 Next-of-Kin RelatedPerson example

6.48 Nuclear Pleomorphism Observation Example

6.49 Number of Sentinel Nodes Examined

6.50 Observation for Clock Position General

6.51 Oncologist Practitioner example

6.52 Oncologist PractitionerRole example

6.53 Overall Grade Observation Example

6.54 Pathologist Practitioner example

6.55 Pathology specimen collection procedure example

6.56 Patient Age Group Observation example

6.57 Patient example

6.58 Primary Tumor Observation example

6.59 Principal Pathology Lab example

6.60 PTNM Classification Observation example

6.61 pTNM Classification Section

6.62 Redwood Women's Center, P.C. example

6.63 Regional Lymph Nodes Observation example

6.64 Regional Lymph Nodes PT Category Observation example

6.65 Regional Lymph Nodes Section

6.66 Regional Lymph Nodes Status Observation example

6.67 Service Request - Cancer Pathology example

6.68 Special Studies Estrogen Receptor

6.69 Special Studies Section

6.70 Specific Clock Position Observation (8 o'clock)

6.71 Specimen Laterality Observation Example

6.72 Specimen Section

6.73 Surgeon Practitioner example

6.74 Surgeon PractitionerRole example

6.75 TNM Descriptors Observation example

6.76 Total Number of Lymph Nodes Examined (sentinel and non-sentinel) example

6.77 Tumor Extension Observation example

6.78 Tumor Extent Observation Example

6.79 Tumor Focality Observation Example

6.80 Tumor Invasion Observation example

6.81 Tumor Section

6.82 Tumor Size Observation

6.83 Tumor Weight Observation example

6.84 US Pathologist PractitionerRole example

6.85 US Pathology Breast Invasive Carcinoma DiagnosticReport example

6.86 US Pathology Encounter Specimen Collection example

6.87 US Pathology Exchange bundle example

6.88 expansion-parameters-fhir-cancer-ig